NO890594D0 - Fremgangsmaate for fremstilling av fem-leddede ringsystemer med bundne azacykliske ringsubstituenter. - Google Patents
Fremgangsmaate for fremstilling av fem-leddede ringsystemer med bundne azacykliske ringsubstituenter.Info
- Publication number
- NO890594D0 NO890594D0 NO890594A NO890594A NO890594D0 NO 890594 D0 NO890594 D0 NO 890594D0 NO 890594 A NO890594 A NO 890594A NO 890594 A NO890594 A NO 890594A NO 890594 D0 NO890594 D0 NO 890594D0
- Authority
- NO
- Norway
- Prior art keywords
- ring
- leaded
- bond
- procedure
- manufacture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888803317A GB8803317D0 (en) | 1988-02-12 | 1988-02-12 | Therapeutic agents |
GB888810789A GB8810789D0 (en) | 1988-05-06 | 1988-05-06 | Therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
NO890594D0 true NO890594D0 (no) | 1989-02-10 |
NO890594L NO890594L (no) | 1989-08-14 |
Family
ID=26293485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO89890594A NO890594L (no) | 1988-02-12 | 1989-02-10 | Fremgangsmaate for fremstilling av fem-leddede ringsystemer med bundne azacykliske ringsubstituenter. |
Country Status (15)
Country | Link |
---|---|
US (2) | US4952587A (no) |
EP (1) | EP0328200B1 (no) |
JP (1) | JP2505875B2 (no) |
KR (1) | KR890013011A (no) |
AU (1) | AU614027B2 (no) |
CA (1) | CA1337199C (no) |
DE (1) | DE68911162T2 (no) |
DK (1) | DK61689A (no) |
ES (1) | ES2061928T3 (no) |
FI (1) | FI890657A (no) |
IE (1) | IE890431L (no) |
IL (1) | IL89165A0 (no) |
NO (1) | NO890594L (no) |
NZ (1) | NZ227841A (no) |
PT (1) | PT89613B (no) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8717446D0 (en) * | 1987-07-23 | 1987-08-26 | Merck Sharp & Dohme | Chemical compounds |
NZ225999A (en) * | 1987-09-10 | 1992-04-28 | Merck Sharp & Dohme | Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions |
US5264444A (en) * | 1989-02-22 | 1993-11-23 | Novo Nordisk A/S | Piperidine compounds and use |
US5328925A (en) * | 1989-02-22 | 1994-07-12 | Novo Nordisk A/S | Piperidine compounds and their use |
US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
US5260311A (en) * | 1989-02-22 | 1993-11-09 | Novo Nordisk A/S | Piperidine compounds and their use |
IL96891A0 (en) * | 1990-01-17 | 1992-03-29 | Merck Sharp & Dohme | Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them |
DK198590D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
DK198390D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
US5376668A (en) * | 1990-08-21 | 1994-12-27 | Novo Nordisk A/S | Heterocyclic compounds |
US5418240A (en) * | 1990-08-21 | 1995-05-23 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
USRE35822E (en) * | 1990-08-21 | 1998-06-09 | Novo Nordisk A/S | Heterocyclic compounds |
DK198490D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
US5527813A (en) * | 1990-08-21 | 1996-06-18 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
HU209451B (en) * | 1990-11-05 | 1994-06-28 | Gyogyszerkutato Intezet | Process for the production of 1-azabicyclo-alkan -derivatives and pharmaceutical preparations containing the same |
AU9102991A (en) * | 1990-11-29 | 1992-06-25 | Rhone-Poulenc Rorer International (Holdings) Inc. | 2,6-methano-2h-1-benzoxocincarboxamides as 5-ht3-antagonists |
EP0494774A1 (en) * | 1991-01-11 | 1992-07-15 | MERCK SHARP & DOHME LTD. | Indazole-substituted fivemembered heteroaromatic compounds |
US5317103A (en) * | 1991-01-15 | 1994-05-31 | Merck Sharp & Dohme Limited | Indole-substituted five-membered heteroaromatic compounds as 5-HT1 agonists |
CZ283018B6 (cs) * | 1991-02-01 | 1997-12-17 | Merck Sharp And Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi |
DE4115215A1 (de) * | 1991-05-10 | 1992-11-12 | Merck Patent Gmbh | Indolderivate |
WO1993002677A1 (en) * | 1991-08-03 | 1993-02-18 | Smithkline Beecham Plc | 5-ht4 receptor antagonists |
US5641791A (en) * | 1991-08-13 | 1997-06-24 | Novo Nordisk A.S | Heterocyclic compounds and their preparation and use |
GB9122988D0 (en) * | 1991-10-30 | 1991-12-18 | Ici Plc | Heterocyclic compounds |
GB9127279D0 (en) * | 1991-12-23 | 1992-02-19 | Ici Plc | Heterocyclic derivatives |
AU3171493A (en) * | 1991-12-31 | 1993-07-28 | Fujisawa Pharmaceutical Co., Ltd. | Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
WO1993014089A1 (en) * | 1992-01-13 | 1993-07-22 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
US5244906A (en) * | 1992-01-23 | 1993-09-14 | Dowelanco | Insect control with substituted oxadiazole and thiadiazole compounds |
US5852014A (en) * | 1992-03-12 | 1998-12-22 | Smithkline Beecham P.L.C. | Condensed indole derivatives as 5HT4 -receptor antagonists |
GB9207396D0 (en) * | 1992-04-03 | 1992-05-13 | Merck Sharp & Dohme | Therapeutic agents |
CA2093778A1 (en) * | 1992-04-10 | 1993-10-11 | George R. Brown | Heterocyclic compounds |
GB9208463D0 (en) * | 1992-04-16 | 1992-06-03 | Merck Sharp & Dohme | Therapeutic agents |
SE9201478D0 (sv) * | 1992-05-11 | 1992-05-11 | Kabi Pharmacia Ab | Heteroaromatic quinuclidinenes, their use and preparation |
GB9211796D0 (en) * | 1992-06-04 | 1992-07-15 | Ici Plc | Heterocyclic derivatives |
IL106445A (en) * | 1992-07-30 | 1998-01-04 | Merck Sharp & Dohme | History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them |
GB9216721D0 (en) * | 1992-08-06 | 1992-09-23 | Ici Plc | Therapeutic heterocyclic derivatives |
GB9218334D0 (en) * | 1992-08-28 | 1992-10-14 | Ici Plc | Heterocyclic compounds |
CA2101599A1 (en) * | 1992-08-31 | 1994-03-01 | Wilhelm Bannwarth | Tri- and tetracyclic compounds |
AU5150393A (en) * | 1992-10-13 | 1994-05-09 | Smithkline Beecham Plc | Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists |
ES2062921B1 (es) * | 1992-11-06 | 1995-06-16 | Merck Patent Gmbh | 3-(indol-2-carboxiamido)quinuclidinas. |
GB9226573D0 (en) * | 1992-12-21 | 1993-02-17 | Ici Plc | Heterocyclic compounds |
GB9314973D0 (en) * | 1993-07-20 | 1993-09-01 | Smithkline Beecham Plc | Medicaments |
PT714394E (pt) * | 1993-08-19 | 2001-12-28 | Novo Nordisk As | Metodo antipsicotico com derivados de tiadiazol e oxadiazol |
US5753683A (en) * | 1993-08-19 | 1998-05-19 | Novo Nordisk A/S | Antipsychotic method |
US5663182A (en) * | 1993-08-19 | 1997-09-02 | Bymaster; Franklin Porter | Antipsychotic method |
MX9603998A (es) * | 1994-03-11 | 1997-12-31 | Yamanouchi Pharma Co Ltd | Agonista receptor de 5-ht3, derivado de tiazol novedoso e intermediario del mismo. |
AU6856094A (en) * | 1994-06-01 | 1995-12-21 | Yamanouchi Pharmaceutical Co., Ltd. | Oxadiazole derivative and medicinal composition thereof |
US5726193A (en) * | 1994-10-31 | 1998-03-10 | Eli Lilly And Company | Method for treating anxiety |
US5612351A (en) * | 1994-11-08 | 1997-03-18 | Novo Nordisk A/S | Method of treating urinary bladder dysfunctions |
US5733912A (en) * | 1997-02-19 | 1998-03-31 | Abbott Laboratories | 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission |
US6107313A (en) * | 1998-10-02 | 2000-08-22 | Combichem, Inc. | Dopamine receptor antagonists |
JP2002533438A (ja) | 1998-12-24 | 2002-10-08 | アベンティス・ファーマスーティカルズ・プロダクツ・インコーポレイテツド | 置換された(アミノイミノメチル又はアミノメチル)ベンゾヘテロアリール化合物 |
AUPR118000A0 (en) | 2000-11-02 | 2000-11-23 | Amrad Operations Pty. Limited | Therapeutic molecules and methods |
EP1380576B1 (en) | 2001-04-16 | 2009-11-25 | Eisai R&D Management Co., Ltd. | 1h-indazole compounds inhibiting jnk |
US20040087642A1 (en) * | 2002-10-24 | 2004-05-06 | Zeldis Jerome B. | Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain |
DE10253426B4 (de) * | 2002-11-15 | 2005-09-22 | Elbion Ag | Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung |
US7332508B2 (en) * | 2002-12-18 | 2008-02-19 | Novo Nordisk A/S | Substituted homopiperidine, piperidine or pyrrolidine derivatives |
WO2005060961A2 (en) * | 2003-12-18 | 2005-07-07 | Astrazeneca Ab | Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd) |
WO2005077373A2 (en) * | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Treatment of gastro-esophageal reflux disease (gerd) |
WO2005077368A2 (en) * | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Treatment of gastro-esophageal reflux disease (gerd) |
TWI330635B (en) * | 2004-03-05 | 2010-09-21 | Organon Nv | (indol-3-yl)-heterocycle derivatives |
MX2007007024A (es) * | 2004-12-16 | 2007-07-04 | Astrazeneca Ab | Ligandos del receptor acetilcolina nicotinica. |
DE102007002717A1 (de) | 2007-01-18 | 2008-07-24 | Merck Patent Gmbh | Heterocyclische Indazolderivate |
DE102007022565A1 (de) | 2007-05-14 | 2008-11-20 | Merck Patent Gmbh | Heterocyclische Indazolderivate |
DE102008038220A1 (de) | 2008-08-18 | 2010-02-25 | Merck Patent Gmbh | Oxadiazolderivate |
DE102008038221A1 (de) | 2008-08-18 | 2010-02-25 | Merck Patent Gmbh | 7-Azaindolderivate |
DE102008038222A1 (de) | 2008-08-18 | 2010-02-25 | Merck Patent Gmbh | Indazol-5-carbonsäurehydrazid-derivate |
HUP1000598A2 (en) | 2010-11-05 | 2012-09-28 | Richter Gedeon Nyrt | Indole derivatives |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3141019A (en) * | 1964-07-14 | Chaohj | ||
US3646053A (en) * | 1970-05-18 | 1972-02-29 | American Cyanamid Co | Certain-(2-amino-4-thiazolyl)indoles |
US4342769A (en) * | 1978-10-02 | 1982-08-03 | Schering Corporation | 2-[(Methylsulfinyl)acetyl]-3-heterocyclicindoles and derivatives thereof as immunosuppressants |
US4203990A (en) * | 1979-04-30 | 1980-05-20 | G. D. Searle & Co. | Anti-diarrheal 2-substituted quinuclidines |
DE3164982D1 (de) * | 1980-04-10 | 1984-08-30 | Sandoz Ag | Isoxazolyl indolamines |
FR2548666A1 (fr) * | 1983-07-08 | 1985-01-11 | Delalande Sa | Nouveaux derives du nor-tropane et du granatane, leur procede de preparation et leur application en therapeutique |
DE3545981A1 (de) * | 1985-01-07 | 1986-07-10 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue carbocyclische und heterocyclische carbonylmethylen und methylpiperidine und -pyrrolidine |
NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
DE3789039T2 (de) * | 1986-06-27 | 1994-06-09 | Beecham Group Plc | Verbrückte bicyclische N-heterocyclische Verbindungen. |
NL8701682A (nl) * | 1986-07-30 | 1988-02-16 | Sandoz Ag | Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten. |
EP0272810A3 (en) * | 1986-11-26 | 1988-07-20 | Harbor Branch Oceanographic Institution, Inc. | Antitumor and antiviral alkaloids |
-
1989
- 1989-02-02 NZ NZ227841A patent/NZ227841A/xx unknown
- 1989-02-03 EP EP89200244A patent/EP0328200B1/en not_active Expired - Lifetime
- 1989-02-03 PT PT89613A patent/PT89613B/pt not_active IP Right Cessation
- 1989-02-03 DE DE68911162T patent/DE68911162T2/de not_active Expired - Fee Related
- 1989-02-03 IL IL89165A patent/IL89165A0/xx unknown
- 1989-02-03 ES ES89200244T patent/ES2061928T3/es not_active Expired - Lifetime
- 1989-02-03 US US07/306,007 patent/US4952587A/en not_active Expired - Lifetime
- 1989-02-09 JP JP1028813A patent/JP2505875B2/ja not_active Expired - Lifetime
- 1989-02-10 NO NO89890594A patent/NO890594L/no unknown
- 1989-02-10 DK DK061689A patent/DK61689A/da not_active Application Discontinuation
- 1989-02-10 KR KR1019890001512A patent/KR890013011A/ko not_active Application Discontinuation
- 1989-02-10 AU AU29860/89A patent/AU614027B2/en not_active Ceased
- 1989-02-10 IE IE890431A patent/IE890431L/xx unknown
- 1989-02-10 CA CA000590772A patent/CA1337199C/en not_active Expired - Fee Related
- 1989-02-10 FI FI890657A patent/FI890657A/fi not_active Application Discontinuation
-
1990
- 1990-07-13 US US07/552,395 patent/US5041456A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2505875B2 (ja) | 1996-06-12 |
AU614027B2 (en) | 1991-08-15 |
IL89165A0 (en) | 1989-09-10 |
CA1337199C (en) | 1995-10-03 |
DK61689A (da) | 1989-08-13 |
IE890431L (en) | 1989-08-12 |
DE68911162T2 (de) | 1994-05-26 |
PT89613B (pt) | 1994-05-31 |
EP0328200B1 (en) | 1993-12-08 |
DK61689D0 (da) | 1989-02-10 |
FI890657A (fi) | 1989-08-13 |
FI890657A0 (fi) | 1989-02-10 |
US5041456A (en) | 1991-08-20 |
DE68911162D1 (de) | 1994-01-20 |
PT89613A (pt) | 1989-10-04 |
NZ227841A (en) | 1991-08-27 |
AU2986089A (en) | 1989-08-17 |
EP0328200A1 (en) | 1989-08-16 |
JPH01268687A (ja) | 1989-10-26 |
NO890594L (no) | 1989-08-14 |
US4952587A (en) | 1990-08-28 |
KR890013011A (ko) | 1989-09-20 |
ES2061928T3 (es) | 1994-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO890594L (no) | Fremgangsmaate for fremstilling av fem-leddede ringsystemer med bundne azacykliske ringsubstituenter. | |
NO884623L (no) | Fremgangsmaate for fremstilling av silisiumkarbid. | |
NO892420D0 (no) | Fremgangsmaate for fremstilling av laminerte materialer. | |
NO880268D0 (no) | Fremgangsmaate for fremstilling av anti-koagulerende peptider. | |
NO885359D0 (no) | Fremgangsmaate for fremstilling av sprengstoff. | |
NO885454D0 (no) | Fremgangsmaate for fremstilling av triklormonosilan. | |
NO894210L (no) | Fremgangsmaate for fremstilling av kinolyloxazol-2-oner. | |
NO894649D0 (no) | Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid. | |
NO890483D0 (no) | Framgangsmaate for tilvirkning av formlegemer. | |
NO882893D0 (no) | Fremgangsmaate for fremstilling av ureaformaldehydharpiks. | |
NO895032L (no) | Fremgangsmaate for fremstilling av 2-benzotiazoliner. | |
NO890159D0 (no) | Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler. | |
NO895158D0 (no) | Fremgangsmaate for fremstilling av antiretrovirale furanketoner. | |
NO885200L (no) | Fremgangsmaate for fremstilling av pro-legemidler. | |
NO895040D0 (no) | Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer. | |
NO870828D0 (no) | Fremgangsmaate for fremstilling av biskarbamater. | |
FI841461A0 (fi) | Foerfarande foer framstaellning av nya substituerade piperazin-1-yl-aettiksyra-amider. | |
NO164356C (no) | Fremgangsmaate for fremstilling av formskummede polyuretankomposittmaterialer. | |
NO891941D0 (no) | Fremgangsmaate for fremstilling av cycloalkadiener. | |
NO160505C (no) | Fremgangsmaate til fremstilling av kunstig rutil. | |
FI880472A0 (fi) | Anordning foer soenderdelning av potatisblast. | |
NO875268D0 (no) | Fremgangsmaate for fremstilling av urea-formaldehydharpikser. | |
NO910420L (no) | Fremgangsmaate for fremstilling av slipepartikler. | |
NO890819D0 (no) | Fremgangsmaate for fremstilling av hydroksybenzaldehyder. | |
NO870882D0 (no) | Fremgangsmaate for fremstilling av takfolie. |